415 related articles for article (PubMed ID: 25087979)
1. The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation.
Tremblay AM; Missiaglia E; Galli GG; Hettmer S; Urcia R; Carrara M; Judson RN; Thway K; Nadal G; Selfe JL; Murray G; Calogero RA; De Bari C; Zammit PS; Delorenzi M; Wagers AJ; Shipley J; Wackerhage H; Camargo FD
Cancer Cell; 2014 Aug; 26(2):273-87. PubMed ID: 25087979
[TBL] [Abstract][Full Text] [Related]
2. YAPping about differentiation therapy in muscle cancer.
Svalina MN; Keller C
Cancer Cell; 2014 Aug; 26(2):154-5. PubMed ID: 25117705
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the relationship between the KRAS G12V oncogene and the Hippo effector YAP1 in embryonal rhabdomyosarcoma.
Mohamed AD; Shah N; Hettmer S; Vargesson N; Wackerhage H
Sci Rep; 2018 Oct; 8(1):15674. PubMed ID: 30353028
[TBL] [Abstract][Full Text] [Related]
4. The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma.
Mohamed A; Sun C; De Mello V; Selfe J; Missiaglia E; Shipley J; Murray GI; Zammit PS; Wackerhage H
J Pathol; 2016 Sep; 240(1):3-14. PubMed ID: 27184927
[TBL] [Abstract][Full Text] [Related]
5. YAP1 enhances NF-κB-dependent and independent effects on clock-mediated unfolded protein responses and autophagy in sarcoma.
Rivera-Reyes A; Ye S; E Marino G; Egolf S; E Ciotti G; Chor S; Liu Y; Posimo JM; Park PMC; Pak K; Babichev Y; Sostre-Colón J; Tameire F; Leli NM; Koumenis C; C Brady D; Mancuso A; Weber K; Gladdy R; Qi J; Eisinger-Mathason TSK
Cell Death Dis; 2018 Oct; 9(11):1108. PubMed ID: 30382078
[TBL] [Abstract][Full Text] [Related]
6. CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG.
Liu Z; Zhang X; Lei H; Lam N; Carter S; Yockey O; Xu M; Mendoza A; Hernandez ER; Wei JS; Khan J; Yohe ME; Shern JF; Thiele CJ
Nat Commun; 2020 Feb; 11(1):911. PubMed ID: 32060262
[TBL] [Abstract][Full Text] [Related]
7. YAP1-TEAD1 signaling controls angiogenesis and mitochondrial biogenesis through PGC1α.
Mammoto A; Muyleart M; Kadlec A; Gutterman D; Mammoto T
Microvasc Res; 2018 Sep; 119():73-83. PubMed ID: 29680477
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis.
Belyea BC; Naini S; Bentley RC; Linardic CM
Clin Cancer Res; 2011 Dec; 17(23):7324-36. PubMed ID: 21948088
[TBL] [Abstract][Full Text] [Related]
9. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.
Ota M; Sasaki H
Development; 2008 Dec; 135(24):4059-69. PubMed ID: 19004856
[TBL] [Abstract][Full Text] [Related]
10. Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood Rhabdomyosarcoma.
Slemmons KK; Yeung C; Baumgart JT; Juarez JOM; McCalla A; Helman LJ
Cancer Res; 2020 Jul; 80(14):3046-3056. PubMed ID: 32354737
[TBL] [Abstract][Full Text] [Related]
11. A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma.
Slemmons KK; Crose LES; Riedel S; Sushnitha M; Belyea B; Linardic CM
Mol Cancer Res; 2017 Dec; 15(12):1777-1791. PubMed ID: 28923841
[TBL] [Abstract][Full Text] [Related]
12. RAGE signaling deficiency in rhabdomyosarcoma cells causes upregulation of PAX7 and uncontrolled proliferation.
Riuzzi F; Sorci G; Sagheddu R; Sidoni A; Alaggio R; Ninfo V; Donato R
J Cell Sci; 2014 Apr; 127(Pt 8):1699-711. PubMed ID: 24554430
[TBL] [Abstract][Full Text] [Related]
13. "Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines".
Sanna L; Piredda R; Marchesi I; Bordoni V; Forcales SV; Calvisi DF; Bagella L
Chem Biol Interact; 2019 Oct; 312():108813. PubMed ID: 31494105
[TBL] [Abstract][Full Text] [Related]
14. YAP1-TEAD1-Glut1 axis dictates the oncogenic phenotypes of breast cancer cells by modulating glycolysis.
Lin C; Xu X
Biomed Pharmacother; 2017 Nov; 95():789-794. PubMed ID: 28892790
[TBL] [Abstract][Full Text] [Related]
15. YAP1 and PRDM14 converge to promote cell survival and tumorigenesis.
Kim M; Ly SH; Xie Y; Duronio GN; Ford-Roshon D; Hwang JH; Sulahian R; Rennhack JP; So J; Gjoerup O; Talamas JA; Grandclaudon M; Long HW; Doench JG; Sethi NS; Giannakis M; Hahn WC
Dev Cell; 2022 Jan; 57(2):212-227.e8. PubMed ID: 34990589
[TBL] [Abstract][Full Text] [Related]
16. Impaired Wnt signaling in embryonal rhabdomyosarcoma cells from p53/c-fos double mutant mice.
Singh S; Vinson C; Gurley CM; Nolen GT; Beggs ML; Nagarajan R; Wagner EF; Parham DM; Peterson CA
Am J Pathol; 2010 Oct; 177(4):2055-66. PubMed ID: 20829439
[TBL] [Abstract][Full Text] [Related]
17. YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis.
Ye S; Lawlor MA; Rivera-Reyes A; Egolf S; Chor S; Pak K; Ciotti GE; Lee AC; Marino GE; Shah J; Niedzwicki D; Weber K; Park PMC; Alam MZ; Grazioli A; Haldar M; Xu M; Perry JA; Qi J; Eisinger-Mathason TSK
Cancer Res; 2018 May; 78(10):2705-2720. PubMed ID: 29490948
[TBL] [Abstract][Full Text] [Related]
18. Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease.
Simile MM; Latte G; Demartis MI; Brozzetti S; Calvisi DF; Porcu A; Feo CF; Seddaiu MA; Daino L; Berasain C; Tomasi ML; Avila MA; Feo F; Pascale RM
Oncotarget; 2016 Aug; 7(31):49194-49216. PubMed ID: 27359056
[TBL] [Abstract][Full Text] [Related]
19. YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers.
Stein C; Bardet AF; Roma G; Bergling S; Clay I; Ruchti A; Agarinis C; Schmelzle T; Bouwmeester T; Schübeler D; Bauer A
PLoS Genet; 2015 Aug; 11(8):e1005465. PubMed ID: 26295846
[TBL] [Abstract][Full Text] [Related]
20. VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle.
Figeac N; Mohamed AD; Sun C; Schönfelder M; Matallanas D; Garcia-Munoz A; Missiaglia E; Collie-Duguid E; De Mello V; Pobbati AV; Pruller J; Jaka O; Harridge SDR; Hong W; Shipley J; Vargesson N; Zammit PS; Wackerhage H
J Cell Sci; 2019 Jul; 132(13):. PubMed ID: 31138678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
